E2F1 and cancer: The overexpression of E2F1 is a sign of transformation and progression in various types of cancer, such as melanoma (Nelson et al., 2006), bladder cancer (Mun et al., 2020), and breast and lung carcinomas (Tsantoulis and Gorgoulis, 2005).